Literature DB >> 5435146

Positioning of subject and of nasogastric tube during a gastric secretion study.

M A Hassan, M Hobsley.   

Abstract

The histamine-infusion test was conducted in 50 subjects with a modification that allowed the completeness of recovery of the maximal gastric secretion to be assessed. The effects of the exact position of the tube and the position of the subject on the completeness of recovery were investigated. A simple water-recovery test was found to be as reliable as fluoroscopy for showing that the tip of the tube was within the stomach. Provided that the tip was within the stomach, the exact position of the tube did not affect recovery. Furthermore, recovery in 19 subjects was not appreciably affected by changing the person from the left lateral to the supine semirecumbent position.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5435146      PMCID: PMC1699461          DOI: 10.1136/bmj.1.5694.458

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  THE HISTAMINE-INFUSION TEST.

Authors:  J H LAWRIE; G M SMITH; A P FORREST
Journal:  Lancet       Date:  1964-08-08       Impact factor: 79.321

2.  Gastric analysis; evaluation of collection techniques.

Authors:  D H JOHNSTON; B H McCRAW
Journal:  Gastroenterology       Date:  1958-11       Impact factor: 22.682

3.  The augmented histamine test.

Authors:  I N MARKS
Journal:  Gastroenterology       Date:  1961-12       Impact factor: 22.682

4.  Use of an inert marker (phenol red) to improve accuracy in gastric secretion studies.

Authors:  M Hobsley; W Silen
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

5.  Improved method for studying the rate of human gastric secretory activity under varying conditions of acid-base balance.

Authors:  M Hobsley; W Silen
Journal:  Surg Forum       Date:  1966

6.  Studies of basal and peak acid output with an augmented histamine test.

Authors:  J H BARON
Journal:  Gut       Date:  1963-06       Impact factor: 23.059

  6 in total
  63 in total

1.  Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Authors:  A B R Thomson; M Keelan; R Lastiwka; S Appelman-Eszczuk; L Zuk; L Drozdowski; A Prentice; P Sinclair
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

2.  Dose ranging study of lansoprazole, a new proton pump inhibitor, in patients with high gastric acid secretion.

Authors:  I Berlin; P Molinier; A Duchier; A Cournot; J Durrel; F Dellatolas; J Duchier
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  The predictive accuracy of the postvagotomy insulin test: A new interpretation.

Authors:  R G Faber; R C Russell; J V Parkin; P Whitfield; M Hobsley
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

4.  Quantitative relation between gastric acid secretion and changes in urinary acid excretion.

Authors:  C D Johnson; P A Harris; C Wastell
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

5.  Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.

Authors:  C W Howden; J A Forrest; J L Reid
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

6.  Comparative evaluation of water recovery test and fluoroscopic screening in positioning a nasogastric tube during gastric secretory studies.

Authors:  J M Findlay; R J Prescott; W Sircus
Journal:  Br Med J       Date:  1972-11-25

7.  Epidermal growth factor in saliva and gastric juice: response to histamine.

Authors:  A M Tunio; M Hobsley
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

8.  Duodenal reflux during insulin-stimulated secretion.

Authors:  R G Faber; R C Russell; C M Royston; P Whitfield; M Hobsley
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

9.  Effect of simulated intragastric haemorrhage on gastric acid secretion, gastric motility, and serum gastrin.

Authors:  G M Fullarton; E J Boyd; G P Crean; T E Hilditch; K E McColl
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

10.  Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure.

Authors:  C W Howden; C D Payton; P A Meredith; D M Hughes; A I Macdougall; J L Reid; J A Forrest
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.